Jon Berggren
Stock Analyst at Kepler Capital
(4.26)
# 1,337
Out of 4,339 analysts
72
Total ratings
61.1%
Success rate
17.8%
Average return
Main Sectors:
Stocks Rated by Jon Berggren
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: 0MGB Genmab A/S | Maintained: Hold | $2,100 | $1,723.63 | +21.84% | 4 | May 7, 2026 | |
| STO: SOBI Swedish Orphan Biovitrum AB (publ) | Maintained: Buy | $350 | $447.20 | -21.74% | 14 | Apr 29, 2026 | |
| STO: DYVOX Dynavox Group AB (publ) | Maintained: Hold | $125 → $90 | $82.00 | +9.76% | 7 | Apr 27, 2026 | |
| FRA: 7XE Nightingale Health Oyj | Maintained: Sell | $1 | $0.75199997 | n/a | 3 | Mar 27, 2025 | |
| AIM: FARN Faron Pharmaceuticals Oy | Maintained: Sell | $0.9 → $0.8 | $41.50 | n/a | 4 | Feb 28, 2025 | |
| FRA: 4YL Nanoform Finland Oyj | Maintained: Buy | $3 | $0.85799998 | n/a | 3 | Feb 27, 2025 | |
| LON: 0KFH Revenio Group Oyj | Maintained: Sell | $26 | $20.82 | n/a | 5 | Feb 14, 2025 | |
| STO: BACTI.B Bactiguard Holding AB (publ) | Maintained: Hold | $35 → $30 | $15.90 | n/a | 4 | Feb 7, 2025 | |
| HUM Humana | Maintained: Hold | $25 | $307.95 | n/a | 1 | Apr 4, 2024 | |
| STO: HUM Humana AB (publ) | Maintained: Hold | $25 | $53.90 | n/a | 14 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $2.87 | n/a | 4 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 | $74.05 | n/a | 1 | Jan 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $172 | $67.04 | n/a | 1 | Jan 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $640 | $149.40 | n/a | 1 | Jan 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $4.24 | n/a | 2 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $155 | $15.09 | n/a | 2 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 | $77.46 | n/a | 1 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9,200 | $13,916.00 | n/a | 1 | Dec 17, 2020 |
Genmab A/S
May 7, 2026
Maintained: Hold
Price Target: $2,100
Current: $1,723.63
Upside: +21.84%
Swedish Orphan Biovitrum AB (publ)
Apr 29, 2026
Maintained: Buy
Price Target: $350
Current: $447.20
Upside: -21.74%
Dynavox Group AB (publ)
Apr 27, 2026
Maintained: Hold
Price Target: $125 → $90
Current: $82.00
Upside: +9.76%
Nightingale Health Oyj
Mar 27, 2025
Maintained: Sell
Price Target: $1
Current: $0.75199997
Upside: n/a
Faron Pharmaceuticals Oy
Feb 28, 2025
Maintained: Sell
Price Target: $0.9 → $0.8
Current: $41.50
Upside: n/a
Nanoform Finland Oyj
Feb 27, 2025
Maintained: Buy
Price Target: $3
Current: $0.85799998
Upside: n/a
Revenio Group Oyj
Feb 14, 2025
Maintained: Sell
Price Target: $26
Current: $20.82
Upside: n/a
Bactiguard Holding AB (publ)
Feb 7, 2025
Maintained: Hold
Price Target: $35 → $30
Current: $15.90
Upside: n/a
Humana
Apr 4, 2024
Maintained: Hold
Price Target: $25
Current: $307.95
Upside: n/a
Humana AB (publ)
Apr 4, 2024
Maintained: Hold
Price Target: $25
Current: $53.90
Upside: n/a
Mar 23, 2023
Maintained: Buy
Price Target: $19
Current: $2.87
Upside: n/a
Jan 20, 2022
Maintained: Buy
Price Target: $135
Current: $74.05
Upside: n/a
Jan 20, 2022
Maintained: Hold
Price Target: $172
Current: $67.04
Upside: n/a
Jan 20, 2022
Maintained: Buy
Price Target: $640
Current: $149.40
Upside: n/a
Nov 29, 2021
Maintained: Buy
Price Target: $42
Current: $4.24
Upside: n/a
Nov 29, 2021
Maintained: Buy
Price Target: $155
Current: $15.09
Upside: n/a
Jun 29, 2021
Maintained: Buy
Price Target: $105
Current: $77.46
Upside: n/a
Dec 17, 2020
Maintained: Buy
Price Target: $9,200
Current: $13,916.00
Upside: n/a